LUNG CANCER (NON-SMALL CELL)
Clinical trials for LUNG CANCER (NON-SMALL CELL) explained in plain language.
Never miss a new study
Get alerted when new LUNG CANCER (NON-SMALL CELL) trials appear
Sign up with your email to follow new studies for LUNG CANCER (NON-SMALL CELL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Inhaled virus therapy tested for tough lung cancers
Disease control Recruiting nowThis study is testing an inhaled therapy called KB707 for adults with advanced solid tumors in the lungs that have stopped responding to standard treatments. The therapy uses a modified, harmless virus designed to stimulate the immune system to fight the cancer directly in the lu…
Matched conditions: LUNG CANCER (NON-SMALL CELL)
Phase: PHASE1, PHASE2 • Sponsor: Krystal Biotech, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New drug duo targets 'Undruggable' lung cancer mutation in First-Line trial
Disease control Recruiting nowThis study is testing whether a new combination of two drugs (IBI351 and cetuximab β) can help control advanced lung cancer in people who have not yet received treatment and have a specific genetic change called KRAS G12C. The trial will enroll 48 adults to see how well the tumor…
Matched conditions: LUNG CANCER (NON-SMALL CELL)
Phase: PHASE2 • Sponsor: Guangdong Association of Clinical Trials • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
New weapon tested in fight against tough cancers
Disease control Recruiting nowThis early-stage study is testing a new type of cancer drug called MBRC-201 in people with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find a safe and effective dose and to see how the body processes the drug. The study will en…
Matched conditions: LUNG CANCER (NON-SMALL CELL)
Phase: PHASE1, PHASE2 • Sponsor: MBrace Therapeutics • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
New drug trial aims to fight advanced lung cancer
Disease control Recruiting nowThis study is testing a new drug called SKB571 for people with advanced non-small cell lung cancer. The main goals are to see if the drug is safe and if it can shrink or control tumors. About 190 patients will receive the drug until their cancer gets worse or they have bad side e…
Matched conditions: LUNG CANCER (NON-SMALL CELL)
Phase: PHASE2 • Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 09, 2026 14:26 UTC
-
Weekly calls aim to ease burden for veterans battling lung cancer
Symptom relief Recruiting nowThis study is testing whether weekly phone calls from a trained support worker can improve the quality of life for Veterans with lung cancer. About 194 Veterans will be randomly assigned to either receive these support calls in addition to their usual care, or to receive only the…
Matched conditions: LUNG CANCER (NON-SMALL CELL)
Phase: NA • Sponsor: Palo Alto Veterans Institute for Research • Aim: Symptom relief
Last updated Mar 23, 2026 15:16 UTC
-
Doctors track 500 patients to find best surgery after cancer treatment
Knowledge-focused Recruiting nowThis study follows 500 lung cancer patients who receive immunotherapy drugs before surgery. Researchers want to learn which surgical approach works better after this treatment and whether surgery provides more benefit than radiation. The study tracks patients' long-term health an…
Matched conditions: LUNG CANCER (NON-SMALL CELL)
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC
-
Scientists test 'Crystal Ball' for lung cancer drugs
Knowledge-focused Recruiting nowThis study aims to see if new lab tests and a special type of PET scan can predict how well standard immunotherapy drugs work for people with recurrent non-small cell lung cancer. It will involve about 40 participants whose cancer has returned after initial treatment. The goal is…
Matched conditions: LUNG CANCER (NON-SMALL CELL)
Phase: PHASE1, PHASE2 • Sponsor: GlaxoSmithKline • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:29 UTC
-
New tool lets lung cancer patients help pick their radiation dose
Knowledge-focused Recruiting nowThis study is testing a decision-making tool designed to help patients be more involved in planning their radiation treatment. It's for people with lung tumors very close to the chest wall, where radiation can cause pain or rib fractures. The tool helps patients and doctors toget…
Matched conditions: LUNG CANCER (NON-SMALL CELL)
Phase: NA • Sponsor: Vejle Hospital • Aim: Knowledge-focused
Last updated Mar 20, 2026 14:47 UTC